Literature DB >> 31181967

The Prognostic Significance of EIF3C Gene during the Tumorigenesis of Prostate Cancer.

Jianxin Hu1, Heng Luo2, Yuangao Xu1, Guangheng Luo1, Shuxiong Xu1, Jianguo Zhu1, Dalong Song1, Zhaolin Sun1, Youlin Kuang3.   

Abstract

Prostate cancer (PCa) is the most common malignant tumor for men. But the mechanism is unclear. EIF3C was shown to be overexpressed in PCa tissues and cell lines. EIF3C overexpression was correlated to age and tumor stage in PCa patients and indicated poor survival. The proliferation, migration, and invasiveness of PC3 cells were all inhibited after EIF3C knockdown. Additionally, the phosphorylation level of PI3K and Akt was downregulated while total NF-κB and Myc decreased after EIF3C knockdown. But the expression of IκB increased reversely. Therefore, EIF3C at least partially regulates the activity of PI3K/Akt/NF-κB signaling pathway in PC3 cells.

Entities:  

Keywords:  EIF3C; NF-κB; PI3K/Akt; prostate cancer

Mesh:

Substances:

Year:  2019        PMID: 31181967     DOI: 10.1080/07357907.2019.1618322

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.

Authors:  Lifeng Ding; Ruyue Wang; Qiming Zheng; Danyang Shen; Huan Wang; Zeyi Lu; Wenqin Luo; Haiyun Xie; Liangliang Ren; Minxiao Jiang; Chenhao Yu; Zhenwei Zhou; Yudong Lin; Haohua Lu; Dingwei Xue; Wenjing Su; Liqun Xia; Jochen Neuhaus; Sheng Cheng; Gonghui Li
Journal:  J Exp Clin Cancer Res       Date:  2022-06-02

2.  Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling.

Authors:  Junhong Li; Wandong Yu; Jianchao Ge; Jun Zhang; Yang Wang; Pengyu Wang; Guowei Shi
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

3.  EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.

Authors:  Xiaoli Ding; Lanlan Hou; Huijuan Zhang; Zhiping Chen; Zhanyu Liu; Junjie Gong; Zhixian Tang; Rong Hu
Journal:  Dis Markers       Date:  2022-09-14       Impact factor: 3.464

Review 4.  Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).

Authors:  Hongyuan Wan; Yanyan Feng; Junjie Wu; Lijie Zhu; Yuanyuan Mi
Journal:  Mol Med Rep       Date:  2022-07-20       Impact factor: 3.423

5.  Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Authors:  Geoffroy Walbrecq; Odile Lecha; Anthoula Gaigneaux; Miriam R Fougeras; Demetra Philippidou; Christiane Margue; Milène Tetsi Nomigni; François Bernardin; Gunnar Dittmar; Iris Behrmann; Stephanie Kreis
Journal:  Cancers (Basel)       Date:  2020-03-14       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.